JumpCan

From April 12 to 16, the 2026 Wuzhen Health Conference and the 5th China OTC Conference were grandly held. To promote Chinese pharmaceutical health brand building, enhance the social image and influence of Chinese pharmaceutical health brands, and drive the optimization and upgrading of the pharmaceutical health industry, the eagerly anticipated "the Most Popular Star Product in Pharmacies" selection results were announced during the conference. JumpCan Pharmaceutical's nationally exclusive dosage form, Pudilan Xiaoyan Oral Liquid, successfully won this award by virtue of its excellent quality, outstanding reputation, and impressive market performance — demonstrating the product's core value at retail terminals and solid brand strength.

"the Most Popular Star Product in Pharmacies" selection is grounded in retail terminal channels and the medication needs of the general public. Through a scientific evaluation system encompassing six core dimensions — terminal sales, quality and craftsmanship, channel empowerment, industry-commerce interaction, integrated marketing, and brand social recognition — the selection combines open online voting with quantitative assessment and qualitative analysis by an expert review committee to identify star products with market breakthrough potential, channel support strength, and sustainable development potential, setting value benchmarks for the pharmaceutical health retail sector.

Pudilan Xiaoyan Oral Liquid is a classic Chinese patent medicine for heat-clearing and detoxification, as well as for the treatment of throat and oral diseases. Relying on JumpCan Pharmaceutical's leading quality management system and strictly adhering to authentic medicinal material selection standards and fine processing techniques, it is an exclusive oral liquid dosage form product. With advantages including convenient administration, suitability for both children and adults, wide and effective applications, and strong brand influence, Pudilan Xiaoyan Oral Liquid has won the deep trust of consumers and pharmacy staff, becoming a commonly stocked medicine in many family medicine cabinets. According to Menet data, Pudilan Xiaoyan Oral Liquid ranked first among the Top 20 Brands of Heat-Clearing and Detoxifying TCM Patent Medicines in China's Urban Pharmacies' Oral Liquids category in 2025. Having been converted to OTC status, Pudilan Xiaoyan Oral Liquid can be purchased directly at pharmacies without a prescription, further improving the patients' convenience.

This award represents dual recognition of Pudilan Xiaoyan Oral Liquid's market performance and consumer reputation at the retail terminal, further consolidating its leading position in the retail pharmaceutical market. JumpCan Pharmaceutical has been deeply engaged in the retail market for many years, always centered on patient needs, continuously optimizing retail market deployment, and committed to providing consumers with more convenient drug administration and more effective therapeutic drugs. The company continues to build deep partnerships with national top-100 chains, regional chains, and grassroots pharmacies, while also deploying on mainstream e-commerce platforms such as Tmall and JD.com, opening up full online and offline channels, enhancing product accessibility and terminal service capabilities, and bringing high-quality Chinese medicines into millions of households.

Going forward, JumpCan Pharmaceutical will take this award as an opportunity to continue deepening its engagement in the retail market, maintain the original intention of quality, strengthen channel development and brand communication, contribute to the construction of a "Healthy China," and enable more patients to enjoy high-quality, efficient, and convenient pharmaceutical services.